PLUR

#5148
Pluri Inc. - Common Stock
0.0 2 USD
-99.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.02
0.02
Year Range
0.02
3.88
Daily Change
-99.01%
Monthly Change
-99.33%
6 month change
-99.39%
Year Change
-99.39%
Previous Close
2.3 4
Open
0.0 2
Low
0.0 2
High
0.0 2
Volume
1
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 250.32 K
  • Employee 142
  • Founded 2001
  • CEO Yaky Yanay
  • Website www.pluri-biotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DQX509
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.39
Price to sales ratio
23.48

Pluri Inc. - Common Stock

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.

News